Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
EPA Approval of Enlist Duo Pesticide Violates Federal Law, Petition Claims April 19, 2018 Irvin Jackson Add Your CommentsEnvironmentalists and farmers petitioned federal regulators last week, seeking to reverse the approval of Enlist Duo, an herbicide that combines two active ingredients that critics say become more toxic when mixed together.ย The National Family Farm Coalition, the Center for Biological Diversity, the Natural Resources Defense Council and several other groups filed a petition (PDF) against the U.S. Environmental Protection Agency (EPA) and it’s commissioner Scott Pruitt on April 11, challenging the EPA’s expanded approval of Enlist Duo, a Dow pesticide that combines glyphosate, the active ingredient in Roundup, and 2,4- dichlorophenoxyacetic acid (2,4-D).Early last year, the EPA expanded approval of Enlist Duo in 34 states, for use on corn, cotton and soybean crops that have been genetically modified to withstand the pesticide. However, the petition, filed in the U.S. Court of Appeals for the Ninth Circuit, claims that the EPA failed in its mission to protect the environment, farms, public health and endangered species.ROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe approval came despite a 2015 EPA review, which found that Dow made claims of a โsynergisticโ effect between glyphosate and 2,4-D, which could make the two chemicals more toxic. The information was discovered in patent documents, but the EPA claims Dow never informed the agency that the two could become more powerful, and potentially more dangerous, when combined.The EPA indicates that it contacted Dow after discovering the synergism claims, and warned the company that this would assess how the regulators factored the potential impacts to non-target organisms. Dow responded with more data, which the EPA is still reviewing. However, the preliminary findings led EPA reviewers to conclude that a 30-foot buffer it required around application areas for Enlist Duo may be insufficient.Despite those concerns, the EPA granted expanded approval of the herbicide after the new administration came into office in early 2017.“EPA has put human health, neighboring crops, and the survival and recovery of hundreds of endangered species at risk by recklessly putting a potent and toxic pesticide on the market without the data or expert review the law requires,” Paul Achitoff, an attorney with Earthjustice said in a press release. “We, and the law, demand much more from the agency created to protect our health and environment than bowing to chemical industry pressure.”Glyphosate, the active ingredient most known for its use in Monsantoโs weed killer Roundup, wasย deemed to be a probably carcinogenย in March by the International Agency for Research on Cancer (IARC), an arm of the World Health Organization. The designation has led some countries to ban Roundup and other glyphosate-based pesticides.Monsanto now faces hundreds of Roundup lawsuits by agricultural workers who say they have been diagnosed with non-Hodgkin’s lymphoma due to long-term exposure to glyphosate.The chemical 2,4-D was used in Agent Orange, a defoliant during the Vietnam War, which has been linked to a number of illnesses afflicting veterans of the war.The petition calls for the appeals court to vacate the EPA’s approval, saying that the agency violated both the Endangered Species Act and the Federal Insecticide, Fungicide, and Rodenticide Act. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Chemicals, Dow, Enlist Duo, Glyphosate, Herbicide, RoundupMore Roundup Lawsuit Stories Roundup Cancer Lawsuit Trial Underway in Missouri Court October 5, 2026 U.S. Supreme Court Blocks Roundup Lawsuits Over Non-Hodgkin’s Lymphoma Warnings June 25, 2026 Roundup Class Action Lawsuit Linked to $7.2B NHL Settlement Transferred to Federal MDL June 2, 2026 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Covidien ProGrip Mesh Lawsuit Scheduled for March 2027 Jury Trial (Posted: today)A federal judge has selected the third claim to serve as a Covidien hernia mesh bellwether trial, which will begin in March.MORE ABOUT: HERNIA MESH LAWSUITJudge Sets Next Covidien Hernia Mesh Lawsuit for Trial in January 2027 (09/11/2026)Covidien Mesh Lawyers to Meet With MDL Judge This Week, Following Landmark Verdict (08/17/2026)Covidien Hernia Mesh Lawsuit Payout of $88M Awarded in First MDL Bellwether Trial (08/05/2026) Abbott and Nevro Spinal Cord Stimulator Lawsuits Centralized in New Federal MDLs (Posted: yesterday)Federally filed lawsuits against Abbott Laboratories and Nevro over alleged spinal cord stimulator injuries have been consolidated into two separate multidistrict litigations in California and Illinois.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITSpinal Cord Stimulator Lawsuit Alleges Boston Scientific Device Failure Required Removal Surgery (09/29/2026)Nevro SCS Implant Lawsuit Alleges Sales Rep Programming Led to Permanent Nerve Damage (09/21/2026)Boston Scientific Spine Stimulator Lawsuit Filed Over Numbness, Incontinence, Erectile Dysfunction (09/16/2026) Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (Posted: 4 days ago)A U.S. District Judge refused to dismiss a Bard PowerPort lawsuit just two weeks before it is supposed to go to trial, saying the manufacturer will have to convince a jury with their arguments and not him.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Set for Third Bellwether Trial to Begin Oct. 13 (09/14/2026)Jury Awards $40M Port Catheter Lawsuit Payout in Bard PowerPort Bellwether Trial (09/09/2026)Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials (08/12/2026)
Covidien ProGrip Mesh Lawsuit Scheduled for March 2027 Jury Trial (Posted: today)A federal judge has selected the third claim to serve as a Covidien hernia mesh bellwether trial, which will begin in March.MORE ABOUT: HERNIA MESH LAWSUITJudge Sets Next Covidien Hernia Mesh Lawsuit for Trial in January 2027 (09/11/2026)Covidien Mesh Lawyers to Meet With MDL Judge This Week, Following Landmark Verdict (08/17/2026)Covidien Hernia Mesh Lawsuit Payout of $88M Awarded in First MDL Bellwether Trial (08/05/2026)
Abbott and Nevro Spinal Cord Stimulator Lawsuits Centralized in New Federal MDLs (Posted: yesterday)Federally filed lawsuits against Abbott Laboratories and Nevro over alleged spinal cord stimulator injuries have been consolidated into two separate multidistrict litigations in California and Illinois.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITSpinal Cord Stimulator Lawsuit Alleges Boston Scientific Device Failure Required Removal Surgery (09/29/2026)Nevro SCS Implant Lawsuit Alleges Sales Rep Programming Led to Permanent Nerve Damage (09/21/2026)Boston Scientific Spine Stimulator Lawsuit Filed Over Numbness, Incontinence, Erectile Dysfunction (09/16/2026)
Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (Posted: 4 days ago)A U.S. District Judge refused to dismiss a Bard PowerPort lawsuit just two weeks before it is supposed to go to trial, saying the manufacturer will have to convince a jury with their arguments and not him.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Set for Third Bellwether Trial to Begin Oct. 13 (09/14/2026)Jury Awards $40M Port Catheter Lawsuit Payout in Bard PowerPort Bellwether Trial (09/09/2026)Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials (08/12/2026)